Abstract
In order to mitigate the inequities in health outcomes and healthcare access for vulnerable populations during the COVID-19 pandemic, the government of India introduced antigen-based SARS-CoV-2 self-testing kits for self-administered use. In this study, we aimed to determine the usability of these nasal-sampling-based self-tests in a peer-assisted model among factory workers in Bengaluru. The mixed-method cross-sectional study was conducted with 106 factory workers, spanning two sites from February to March 2022 in Bengaluru, India. Panbio™ COVID-19 Antigen Self-Test kit and the mobile application NAVICA for self-reporting results were used. A peer assistant distributed test kits, guided participants on conducting tests and using the app, and offered demonstrations with their own kit, ensuring no contact with the participants’ kits. Findings were encapsulated by an observer, who used standardized product-specific usability checklists and pictures of contrived results to assess the usability of the kit and mobile application, result interpretation, and the efficiency of peer instruction/demonstration. Additionally, a post-test survey and focus group discussions with selected participants and peer assistants were conducted to understand user perceptions of the facilitators and barriers to usability. Study findings show that the overall usability score of the test kit with peer assistance was 75.9%, rising to 80.7% for critical steps and 33.8% for all critical steps in uploading results through NAVICA. Additionally, it was seen that peer assistants provided accurate instructions and support for 93.4% of the tests. Among the critical steps in test kit use, maximum errors were made in sample collection and using the correct amount of buffer solution. Concordance between the participant and observer/NAVICA was 97.9%. 62.0% and 56.6% of the participants reported confidence in a) performing and interpreting the test and b) capturing and uploading their results using the mobile application with the assistance of a peer, respectively. Less than half the participants reported confidence in performing these steps independently. The study indicates that the COVID-19 nasal self-testing kit has good usability in factories’ peer-assisted workplace testing model. Such models can empower vulnerable worker groups to access early detection and self-care tools equitably.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the German Government through BMZ (Federal Ministry for Economic Cooperation and Development, Germany). The funders had no role in data collection and analysis, the decision to publish, or the preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was received by the Catalyst Foundation Institutional Review Board on January 19, 2022. Participants were informed about the nature, purpose, and possible risks of the study and provided informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The quanitative data underlying this papers findings will be made available upon request to the corresponding author. FIND does not share qualitative data due to our qualitative data sharing standards. FIND is developing a quanitative data sharing policy and once that policy is developed and approved then FIND will be able to share data to open repositories in line with said data sharing policy
List of Abbreviations
- COVID-19
- Coronavirus disease 2019
- SARS-CoV-2
- Severe Acute Respiratory Syndrome CoronaVirus-2
- GDP
- Gross Domestic Product
- RT-PCR
- Reverse transcription polymerase chain reaction
- RAT
- Rapid Antigen Test
- WHO
- World Health Organization
- ICMR
- Indian Council of Medical Research
- GOI
- Government of India
- PPE
- Personal Protective Equipment
- AgRDT
- Antigen based Rapid Diagnostic Test
- PHC
- Primary Health Center
- BBMP
- Bruhat Bengaluru Mahanagara Palike
- IFU
- Instructions for Use
- CHW
- Community Health Worker